BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 26117320)

  • 1. Epigenetic regulation of Keap1-Nrf2 signaling.
    Guo Y; Yu S; Zhang C; Kong AN
    Free Radic Biol Med; 2015 Nov; 88(Pt B):337-349. PubMed ID: 26117320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
    Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
    Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
    Camiña N; Penning TM
    Br J Cancer; 2022 May; 126(9):1244-1252. PubMed ID: 34845361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the Keap1-Nrf2 system.
    Suzuki T; Yamamoto M
    Free Radic Biol Med; 2015 Nov; 88(Pt B):93-100. PubMed ID: 26117331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.
    Dodson M; Redmann M; Rajasekaran NS; Darley-Usmar V; Zhang J
    Biochem J; 2015 Aug; 469(3):347-55. PubMed ID: 26205490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human age‑related cataracts: epigenetic suppression of the nuclear factor erythroid 2‑related factor 2‑mediated antioxidant system.
    Gao Y; Yan Y; Huang T
    Mol Med Rep; 2015 Feb; 11(2):1442-7. PubMed ID: 25370996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy.
    Mishra M; Zhong Q; Kowluru RA
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7256-65. PubMed ID: 25301875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
    Giudice A; Arra C; Turco MC
    Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
    Müller T; Hengstermann A
    Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila.
    Sykiotis GP; Bohmann D
    Dev Cell; 2008 Jan; 14(1):76-85. PubMed ID: 18194654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.